Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Thrombotic microangiopathy associated with interferon beta.
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations.
Receptos reports third quarter 2013 financial results
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod: Risk Assessment and Consensus Recommendations for Management.
Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolomod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
Molecular mechanism underlying the impact of vitamin D on disease activity of MS.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
European Medicines Agency

Pages